JPRN-UMIN000008102已完成未知
The efficacy of salmeterol/fluticasone inhalation on systemic inflammatory markers in patients with chronic obstructive pulmonary diseases - SFC effects on the systemic inflammatory markers in COPD patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •have any of tuberculosis or acute airway infections associated with bronchial asthma had COPD exacerbation in 4 weeks with pregnacy, lactating with any of severe heart disease, liver disease, renal disease, hematological disease or infection disease who the doctor in charge judge as to be excepted
研究者
相似试验
已完成
4 期
Investigation of inhaled Salmeterol/ Fluticasone propionate (SFC) in patient with COPD.Chronic obstructive pulmonary diseaseJPRN-UMIN000006589Hamamatsu University School of Medicine342
已完成
4 期
Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis BronchiectasisBronchiectasisNCT02782312Shanghai Pulmonary Hospital, Shanghai, China120
已完成
不适用
Bronchodilator effects of salmeterol/fluticasone propionate (SFC) in patients with COPDCOPDJPRN-UMIN000002764Atami Hospita International University of Health and Welfare30
已完成
不适用
Salmeterol/Fluticasone Easyhaler in the Treatment of Asthma and COPDChronic Obstructive Pulmonary DiseaseAsthmaNCT03755544Orion Corporation, Orion Pharma231
进行中（未招募）
不适用
Efficacy and safety of Salmeterol/Fluticasone DPI HEXAL versus Seretide™ Accuhaler™ in adolescent and adult patients with moderate-to-severe persistent asthma: A 12-week, multicenter, randomized, double-blind, double-dummy, parallel group studyEUCTR2007-005620-32-LTHEXAL AG472